- Home
- ATOS vs BMHL Comparison
ATOS vs BMHL Comparison
Compare ATOS & BMHL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ATOS
- BMHL
- Stock Information
- Founded
- ATOS 2009
- BMHL 2016
- Country
- ATOS United States
- BMHL Hong Kong
- Employees
- ATOS N/A
- BMHL N/A
- Industry
- ATOS Biotechnology: Pharmaceutical Preparations
- BMHL
- Sector
- ATOS Health Care
- BMHL
- Exchange
- ATOS Nasdaq
- BMHL Nasdaq
- Market Cap
- ATOS 112.7M
- BMHL 96.0M
- IPO Year
- ATOS 2012
- BMHL 2025
- Fundamental
- Price
- ATOS $1.01
- BMHL $3.70
- Analyst Decision
- ATOS Strong Buy
- BMHL
- Analyst Count
- ATOS 3
- BMHL 0
- Target Price
- ATOS $6.25
- BMHL N/A
- AVG Volume (30 Days)
- ATOS 762.2K
- BMHL 5.1K
- Earning Date
- ATOS 11-11-2025
- BMHL 01-01-0001
- Dividend Yield
- ATOS N/A
- BMHL N/A
- EPS Growth
- ATOS N/A
- BMHL 9.50
- EPS
- ATOS N/A
- BMHL 0.05
- Revenue
- ATOS N/A
- BMHL $6,873,097.00
- Revenue This Year
- ATOS N/A
- BMHL N/A
- Revenue Next Year
- ATOS N/A
- BMHL N/A
- P/E Ratio
- ATOS N/A
- BMHL $68.51
- Revenue Growth
- ATOS N/A
- BMHL 66.02
- 52 Week Low
- ATOS $0.55
- BMHL $3.37
- 52 Week High
- ATOS $1.66
- BMHL $4.49
- Technical
- Relative Strength Index (RSI)
- ATOS 77.26
- BMHL N/A
- Support Level
- ATOS $0.81
- BMHL N/A
- Resistance Level
- ATOS $0.90
- BMHL N/A
- Average True Range (ATR)
- ATOS 0.04
- BMHL 0.00
- MACD
- ATOS 0.02
- BMHL 0.00
- Stochastic Oscillator
- ATOS 83.33
- BMHL 0.00
About ATOS Atossa Therapeutics Inc.
Atossa Therapeutics Inc is a clinical stage biopharmaceutical company developing proprietary medicines in areas of unmet medical need in oncology. It focuses on the development of novel therapeutics and delivery methods for the treatment of breast cancer, other breast conditions and COVID-19. The company's drug under development for breast cancer and other breast conditions is Endoxifen. Its two COVID-19 drugs under development are AT-H201, to improve lung function of moderate to severely ill, hospitalized COVID-19 patients by inhalation; and AT-301, a nasal spray for COVID-19 patients for at-home use.
About BMHL Bluemount Holdings Limited Class B Ordinary Shares
Bluemount Holdings Ltd through its operating subsidiaries, it is a Hong Kong-based consulting and advisory and financial services provider, as well as trader of commodities such as luxury timepieces. The financial services includes underwriting and placing services, securities dealing and brokerage services, and asset management services. It provides comprehensive consulting and advisory services on business development strategies to its diverse clientele. Generally, the company provides consulting and advisory business for the following segments: Corporate Finance; and Strategic Communications.